High Hopes for FDA Regulation of CBD Products
FDA regulation of CBD products faces new challenges as the market develops.
Value-Pricing Prescription Drugs
Scholar argues that reducing pricing for prescription drugs may increase innovation.
Pennsylvania Lawmakers Restrict Access to Fentanyl Test Strips
Pennsylvania law prevents people who use drugs from testing for fentanyl and avoiding overdoses.
The Culture of Antibiotics Regulation
Scholars discuss the challenges of promoting antibiotic development and preserving existing drugs.
Regulatory Control of Potentially Addictive Drugs
Scholar explains why the DEA—not FDA—has power over the classification of potentially addictive substances.
Federal Agencies Should Extend Pandemic Flexibilities for Opioid Use Disorder
A new report offers recommendations for extending telehealth treatment of opioid use disorder.
Unlocking Psychedelics’ Medical Potential
Scholars critique the regulation of psychedelic substances and propose reforms for medical research and use.
Regulating Prescription Drug Costs
Experts consider how regulators can make drugs affordable without hindering research and development.
Proposal to Import Prescription Drugs Faces Criticism
Critics of a proposed rule to import drugs from Canada cite safety concerns and other potential problems.
Combatting Drug Shortages
A federal task force proposes regulatory solutions to mitigate drug shortages.
Challenges in Implementing Brazil’s Universal Health Care
Brazil has recently made efforts to streamline the introduction and distribution of drugs.
Regulation and the Opioid Epidemic
This Saturday Seminar explores how regulation addresses and affects opioid use and addiction.